Effect of neoadjuvant chemotherapy in patients with gastric cancer: A PRISMA-compliant systematic review and meta-analysis
BMC Cancer | Feb 07, 2018
Miao ZF, et al. - It was demonstrated in this study that neoadjuvant chemotherapy (NAC) for gastric cancer (GC) afforded significant improvement in the outcomes of survival and disease progression while increasing some toxicity.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
